• Subject: Re: AS/400 Based EDI Solutions
  • From: Lori Hainey <lhainey@xxxxxxxxxxx>
  • Date: Tue, 16 Nov 1999 13:39:24 -0500
  • Organization: Hainey Business Systems, Inc.

Scott,
I have worked with Gentran, Premenos (Harbinger) and Extol in the EDI/400 
arena. I
have been most impressed with the Extol product. You may want to check them out.
Their URL is www.extol.com
Lori.

Scott.Lindstrom@zenith.com wrote:

> Check out      
>http://www.news400.com/products400/buyersguides/Feb99/bg0299.htm
> and       http://www.sterlingcommerce.com/pdsv/ploc/gent/as40.html
>
> We are looking at the same move.
>
> Scott Lindstrom
> Zenith Electronics
>
> "Mark Walter" <mwalter@netrax.net> on 11/12/99 10:37:29 AM
>
> Please respond to MIDRANGE-L@midrange.com
>
> To:   MIDRANGE-L@midrange.com
> cc:    (bcc: Scott R Lindstrom/ITZ/Zenith)
>
> Subject:  AS/400 Based EDI Solutions
>
> All,
>
> My company is looking to implement an AS/400 based EDI solution. Currently we
> are utilizing GENTRAN Director for Windows and the volume is becoming to 
>great.
> I would appreciate any suggestions for AS/400 based EDI software.
>
> tia
>
> Mark Walter
>
>   ------------------------------------------------------------------------
>                   Name: att1.htm
>    att1.htm       Type: Hypertext Markup Language (text/html)
>               Encoding: base64
>            Description: Internet HTML

+---
| This is the Midrange System Mailing List!
| To submit a new message, send your mail to MIDRANGE-L@midrange.com.
| To subscribe to this list send email to MIDRANGE-L-SUB@midrange.com.
| To unsubscribe from this list send email to MIDRANGE-L-UNSUB@midrange.com.
| Questions should be directed to the list owner/operator: david@midrange.com
+---

This thread ...

Replies:

Follow On AppleNews
Return to Archive home page | Return to MIDRANGE.COM home page

This mailing list archive is Copyright 1997-2019 by midrange.com and David Gibbs as a compilation work. Use of the archive is restricted to research of a business or technical nature. Any other uses are prohibited. Full details are available on our policy page. If you have questions about this, please contact [javascript protected email address].